Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity

Gut

Volumn 69, Issue 9, 2020, Pages 1719-1722

  Talley, Nicholas J ^a   Holtmann, Gerald J ^b,c   Jones, Michael ^d   Koloski, Natasha A ^a,c   Walker, Marjorie M ^e   Burns, Grace ^a,e   Potter, Michael D E ^a   Shah, Ayesha ^b,c   Keely, Simon ^e,f  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

anxiety; biomarkers; coeliac disease; functional dyspepsia; irritable bowel syndrome

Indexed keywords

BIOLOGICAL MARKER; UNCLASSIFIED DRUG; ZONULIN; HAPTOGLOBIN; PROTEIN PRECURSOR;

ADULT; CONTROLLED STUDY; DYSPEPSIA; FEMALE; HUMAN; IRRITABLE COLON; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WHEAT ALLERGY; CELIAC DISEASE;

BIOMARKERS; CELIAC DISEASE; DYSPEPSIA; HAPTOGLOBINS; HUMANS; IRRITABLE BOWEL SYNDROME; PROTEIN PRECURSORS; WHEAT HYPERSENSITIVITY;

EID: 85083539977     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2019-318664     Document Type: Letter

References (10)

1. Stevens Br, Goel R, seungbum K, et al. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 Correlated with plasma LPs and altered gut microbiome in anxiety or depression. Gut 2018;67:1555.2-7.
2. Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci 2012;1258:25-33.
3. Dunlop s P, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006;101:1288-94.
4. Lee C, Doo E, Choi JM, et al. the increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J Neurogastroenterol Motil 2017;23:349-62.
5. Aro P, talley NJ, ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (rome III criteria) in a swedish population-based study. Gastroenterology 2009;137:94-100.
6. Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade infammation in functional dyspepsia. Gut 2014;63:262-71.
7. Barbaro Mr. the role of zonulin in non-celiac gluten sensitivity and irritable bowel syndrome. Abstract presented at the 23rd United european gastroenterology week (UeG week 2015), Barcelona, spain, 2015.
8. Ohlsson B, Orho-Melander M, Nilsson P. Higher levels of serum zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations. Int J Mol Sci 2017;18:582.
9. Talley NJ, Holtmann G, Walker MM, et al. Circulating Anti-cytolethal distending toxin B and Anti-vinculin antibodies as biomarkers in community and healthcare populations with functional dyspepsia and irritable bowel syndrome. Clin Transl Gastroenterol 2019;10:e00064.
10. Scheffer L, Crane A, Heyne H, et al. Widely used commercial eLIsA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family. Front Endocrinol 2018;9:22.